Free Trial
OTCMKTS:REMI

Remedent (REMI) Stock Price, News & Analysis

Remedent logo
$0.02 0.00 (-6.50%)
As of 06/3/2025

About Remedent Stock (OTCMKTS:REMI)

Key Stats

Today's Range
$0.0187
$0.0187
50-Day Range
$0.02
$0.05
52-Week Range
$0.02
$0.07
Volume
N/A
Average Volume
66,485 shs
Market Capitalization
$374,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.

Receive REMI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Remedent and its competitors with MarketBeat's FREE daily newsletter.

REMI Stock News Headlines

REMYY Rémy Cointreau SA
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Peterson Remy
Remedent, Inc. (REMI)
See More Headlines

REMI Stock Analysis - Frequently Asked Questions

Remedent's stock was trading at $0.0550 at the beginning of the year. Since then, REMI stock has decreased by 66.0% and is now trading at $0.0187.
View the best growth stocks for 2025 here
.

Shares of REMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Remedent investors own include AbbVie (ABBV), CoStar Group (CSGP), Enterprise Products Partners (EPD), Kellanova (K), Kandi Technologies Group (KNDI), MKS Instruments (MKSI) and M&T Bank (MTB).

Company Calendar

Today
6/04/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:REMI
Employees
4
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$990,000.00
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$374,000.00
Optionable
Not Optionable
Beta
0.03

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:REMI) was last updated on 6/4/2025 by MarketBeat.com Staff
From Our Partners